Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

defibrotide sodium

A polydeoxyribonucleotide with antithrombotic, thrombolytic, and fibrinolytic properties. Defibrotide induces the release of prostaglandin 12 and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
ABSTRACT Introduction: Hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) is an unpredictable condition… Expand
Review
2017
Review
2017
Novel Drugs Passed Muster in 2016 During 2016, the FDA’s Center for Drug Evaluation and Research (CDER) approved 22 novel drugs… Expand
Review
2017
Review
2017
Novel Drugs Passed Muster in 2016 During 2016, the FDA’s Center for Drug Evaluation and Research (CDER) approved 22 novel drugs… Expand
Review
2017
Review
2017
Novel Drugs Passed Muster in 2016 During 2016, the FDA’s Center for Drug Evaluation and Research (CDER) approved 22 novel drugs… Expand
2016
2016
  • M. Choy
  • P & T : a peer-reviewed journal for formulary…
  • 2016
  • Corpus ID: 30695155
Defibrotide sodium (Defitelio) for hepatic veno-occlusive disease; emtricitabine/tenofovir alafenamide (Descovy) for human… Expand